Lisa M. Hillen

Maastricht, LI, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

Prevalence and characteristics of NTRK fusions in 25,946 patients with non-small cell lung cancer.

Prevalence and characteristics of NTRK fusions in 25,946 patients with non-small cell lung cancer.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: June 12, 2026

Line-field confocal versus conventional optical coherence tomography: A head-to-head comparison in basal cell carcinoma diagnosis.

Line-field confocal versus conventional optical coherence tomography: A head-to-head comparison in basal cell carcinoma diagnosis.

Journal: JAAD international

Published: June 08, 2026

Analysis of SLFN11 expression in small cell lung cancer, carcinoids and large cell neuroendocrine carcinoma: insights into lung neuroendocrine neoplasms.

Analysis of SLFN11 expression in small cell lung cancer, carcinoids and large cell neuroendocrine carcinoma: insights into lung neuroendocrine neoplasms.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: April 20, 2026

Quality in Central Pathology Assessment in Pulmonary Carcinoid and Large Cell Neuroendocrine Carcinoma: A Systematic Review.

Quality in Central Pathology Assessment in Pulmonary Carcinoid and Large Cell Neuroendocrine Carcinoma: A Systematic Review.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: April 17, 2026

Clinical utility of molecular profiling in rare lung neuroendocrine neoplasms.

Clinical utility of molecular profiling in rare lung neuroendocrine neoplasms.

Journal: Frontiers in oncology

Published: March 27, 2026

Deep molecular profiling of lung neuroendocrine tumours and supra-carcinoids.

Deep molecular profiling of lung neuroendocrine tumours and supra-carcinoids.

Journal: Molecular cancer

Published: February 27, 2026

Development of a rapid ex vivo tumor platform for drug response prediction in lung cancer.

Development of a rapid ex vivo tumor platform for drug response prediction in lung cancer.

Journal: NPJ precision oncology

Published: February 23, 2026

A 30-year-old male with innumerable millimetric pulmonary nodules: tunnelling thoughts.

A 30-year-old male with innumerable millimetric pulmonary nodules: tunnelling thoughts.

Journal: Respiratory medicine case reports

Published: January 23, 2026

Intratumor immune heterogeneity across simulated core biopsy sizes in non-small cell lung cancer: an exploratory study.

Intratumor immune heterogeneity across simulated core biopsy sizes in non-small cell lung cancer: an exploratory study.

Journal: Translational lung cancer research

Published: January 05, 2026

Pulmonary Neuroendocrine Tumor Artificial Intelligence-Assisted Prediction of Postoperative Recurrence From Tumor Biopsy Specimens.

Pulmonary Neuroendocrine Tumor Artificial Intelligence-Assisted Prediction of Postoperative Recurrence From Tumor Biopsy Specimens.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: December 10, 2025

Actionable Genomic Alterations in Large Cell Neuroendocrine Carcinoma: A European Case Series of Patients Treated With a Small Molecule Inhibitor.

Actionable Genomic Alterations in Large Cell Neuroendocrine Carcinoma: A European Case Series of Patients Treated With a Small Molecule Inhibitor.

Journal: JCO precision oncology

Published: November 14, 2025

Treatment outcomes in patients with stage IV large cell neuroendocrine carcinoma: a nationwide registry study.

Treatment outcomes in patients with stage IV large cell neuroendocrine carcinoma: a nationwide registry study.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: September 01, 2025

Showing 1-12 of 42

Last Updated: 09/26/2026